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Abstract
Objective—Parents and adolescents often decide together whether the child should receive 
human papillomavirus (HPV) vaccine. However, few studies have investigated the dyadic nature 
of beliefs that affect this process.
Method—Data came from the 2010 HPV Immunization in Sons (HIS) Study, a national sample 
of 412 parents and their adolescent sons. We conducted dyadic multivariate logistic regression to 
test the relationships between parents' and sons' HPV vaccine beliefs and their willingness to have 
the son receive the vaccine.
Results—Fewer than half of parents and sons were willing to have the sons receive HPV vaccine 
(43% and 29%, respectively). Willing parents and sons anticipated greater regret if the son did not 
receive HPV vaccine but later contracted an HPV infection (parent odds ratio [OR]=1.72, 95% 
confidence interval [CI]=1.24-2.40; son OR=1.51, 95% CI=1.04-2.19) (both p<.05). Lower 
concerns about side effects, such as pain and fainting, were also associated with willingness.
Conclusion—Parents and sons were more willing to have the son receive HPV vaccine if they 
had higher anticipated regret about potential HPV infection and lower concerns about side effects. 
Communication campaigns should target these beliefs to increase parents' and sons' willingness to 
seek HPV vaccination.
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The three-dose quadrivalent human papillomavirus (HPV) vaccine targets strains of HPV 
that are associated with almost all cases of genital warts1 and a substantial portion of 
anogenital cancers.2 The CDC began recommending routine HPV vaccination for adolescent 
girls in 20073 and for adolescent boys in 2011.4 However, uptake remains low, with only 
57% of girls and 35% of boys receiving at least one dose of the series as of 2013.5
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Parents increasingly share decisions about adolescents' healthcare with their children as they 
get older, including the choice to receive HPV vaccine.6-12 Generally, parents and 
adolescents have similar HPV vaccine beliefs,11,13,14 including their risk appraisals, which 
predict their vaccination intentions and behaviors. However, some beliefs affect parents' and 
adolescents' motivations differently: The promise of preventing cancer encourages 
parents,15,16 while fear of needles or pain discourages adolescents6,9,11,17 from seeking 
vaccination.
In addition to their individual attitudes and beliefs, parents and sons often engage in 
interpersonal negotiation when forming decisions about HPV vaccination (e.g., navigating 
power balance).18,19 In parent-child relationships with relatively young children and a clear 
power imbalance in favor of parents, children may be forced to capitulate to parents' 
decisions. However, in relationships with older children or adolescents, where power may be 
more balanced, more negotiation may be necessary, and “the goal of maintaining the 
relationship appear[s] to become as important as making an effective decision.”19 Thus, 
decision making about HPV vaccination may vary for children of different ages.20
Most previous studies on HPV vaccine beliefs have focused on either the parent or the 
adolescent, without considering how the two members' beliefs operate jointly within a dyad, 
or how this process may vary by adolescent's age. In addition, the bulk of HPV vaccine 
studies have examined vaccination behaviors among girls (given the CDC's earlier 
recommendation for routine vaccination among girls than boys). We aimed to fill these gaps 
by conducting dyadic analyses of the joint contributions of parents' and sons' HPV vaccine 
beliefs on their willingness to have the son vaccinated.
We hypothesized that parents and sons who anticipated greater regret of the son contracting 
HPV without vaccination would express greater vaccination willingness (Hypothesis 1). 
Anticipated regret results from a comparison of one potential outcome (forgoing vaccination 
and later contracting HPV) to another (receiving HPV vaccine and never becoming 
infected); to the extent that parents and sons find the former outcome more aversive than the 
latter, they should be motivated to seek HPV vaccination.21,22 We also hypothesized that 
parents' and sons' willingness would be uniquely motivated by protecting the son from long-
term health effects of HPV infection and immediate side effects of vaccination, respectively 
(Hypothesis 2). When making proxy healthcare decisions, parents are compelled to act in the 
“best interest” of the child,23,24 which should encourage them to evaluate the long-term 
benefits of vaccination (i.e., protection from disease). However, vaccination side effects are 
intrinsically more proximal to sons, and avoidance of discomfort is a powerful motivator of 
health behaviors,25 including vaccination.6,9,11,17 Finally, we examined whether the 
relationship between beliefs and vaccination willingness varied by the age of adolescent 
sons, hypothesizing that parents' beliefs would be less closely related to HPV vaccination 
willingness among older sons than younger sons (Hypothesis 3). We examined these 
hypotheses in a national sample of adolescent boys and their parents.
Moss et al. Page 2















Data came from the parent and son surveys of the HPV Immunization in Sons (HIS) 
Study.26,27 Knowledge Networks (now called GfK) maintains a large, probability-based 
panel of research participants from U.S. households.28 In exchange for completing multiple 
online surveys each month, panel members receive either a laptop computer with free 
internet access or points that they can redeem for small cash payments.
In 2010, Knowledge Networks invited panel members who were parents of boys ages 11 to 
17 to participate in the HIS Study. Of 752 parents who received invitations to participate, 
547 (73%) consented to and completed the parent survey. We excluded from analysis 
parent-son dyads in which the parents did not provide consent for their sons to participate 
(n=119) or the sons did not provide assent (n=7). Finally, we excluded 8 dyads in which the 
son had already received at least one dose of HPV vaccine and 1 dyad in which the son did 
not provide a response for our dependent variable. This resulted in a final analytic sample of 
412 parents matched with their 412 sons.
Procedures
Parents gave informed consent before they began the online survey. Parents with more than 
one son ages 11 through 17 years answered questions about the son with the most recent 
birthday. At the conclusion of the parents' survey, the identified son became eligible to 
complete a separate survey online. Parents provided informed consent for their sons, and 
sons gave assent before beginning the survey. The University of North Carolina Institutional 
Review Board approved the study procedures.
Measures
The complete surveys for the HIS Study are available online (http://www.unc.edu/
~ntbrewer/hpv.htm). Survey items were based on those from our past HPV vaccine 
research.13,29-31 In the current study, we descriptively analyzed awareness of HPV and HPV 
vaccination, and we conducted inferential analysis of the dyadic influences of HPV vaccine 
beliefs on vaccination willingness.
Awareness—Survey items assessed whether participants were aware of HPV and of HPV 
vaccine (Table 1). For participants who were aware of HPV vaccine, an item also assessed 
whether they were aware that adolescent males could receive HPV vaccine. Next, the survey 
presented these statements to all participants: “HPV is a common sexually transmitted 
infection that sometimes leads to genital warts or cancer” and “The HPV vaccine is 
sometimes called the cervical cancer vaccine, Gardasil, or Cervarix. It was first available 
only for females but is now also available for guys. By guys, we mean boys and young men 
9-26 years old.”
Beliefs—Surveys assessed 7 beliefs among parents and sons regarding HPV and HPV 
vaccination (Table 1). These items assessed perceived importance of vaccination, perceived 
likelihood of HPV infection, anticipated regret, and expected pain. For Hypothesis 1, we 
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measured anticipated regret with an item assessing regret about forgoing vaccination if the 
son did not receive HPV vaccine and later developed an HPV infection. For Hypothesis 2, 
we measured concerns about HPV-related diseases with an item assessing perceived 
importance of protecting the son from genital warts and some cancers, and we measured 
concerns about vaccination side effects with items assessing expected pain and anticipated 
regret of fainting from vaccination. For belief items, higher values reflected greater degrees 
of endorsement of that item.
HPV vaccination willingness—Items asked sons how willing they were to receive HPV 
vaccine and parents how willing they were to get HPV vaccine for the son if it were free 
(Table 1). We dichotomized the 5-point response scale: definitely or probably willing (coded 
as 1) or definitely or probably not willing or not sure (coded as 0). Previous studies of HPV 
vaccine attitudes among males have used similar dichotomous measures of willingness.32,33
Demographics—Parent-specific variables were gender (male or female), age (<45 years 
or ≥45 years), and education level (less than college or at least some college). Child-specific 
variables were age (11-12 years, 13-15 years, or 16-17 years), race/ethnicity (non-Hispanic 
white, non-Hispanic black, Hispanic, or other), health insurance coverage (yes or no), and 
uptake of tetanus, diphtheria, and pertussis booster and meningococcal conjugate (yes or no 
for each vaccination variable).
Data analysis
To compare parents' and sons' answers, we used paired t-tests (for continuous variables) or 
McNemar's tests (for dichotomous variables). We calculated Pearson product-moment r 
statistics to measure the non-independence between parents' and sons' responses. Pearson r 
statistics are preferable to intraclass correlations for measuring non-independence among 
dyads whose members' roles are distinguishable.34
To examine whether vaccine beliefs were associated with parents' HPV vaccination 
willingness, we used logistic regression. First, we created “paired” models including two 
independent variables, one for each dyad member's response to a given HPV vaccine belief 
measure, therefore controlling for the other dyad member's responses on the same measure. 
Then, we constructed a multivariate logistic regression model for parents' HPV vaccination 
willingness, including statistically significant correlates (p<.05) from the paired models 
described above. We included both parents' and sons' belief responses in the multivariate 
model, even if only one member's response had a statistically significant relationship in the 
paired models, in order to preserve the dyadic nature of the analysis. Thus, multivariate 
models included both parents' and sons' responses to each HPV vaccine belief measure that 
demonstrated an association with vaccine willingness in the paired models. We repeated 
these analyses using sons' willingness as the outcome. Previous researchers have used 
multivariate regressions to analyze dyadic data in studies of health promotion,35 physical 
activity,36 and healthcare transitions (Sawicki, Keleman, & Weitzman, 2014).37
We used the multivariate models to evaluate Hypotheses 1 and 2. We also used these models 
to examine whether the combined contributions of parents' beliefs differed from sons' beliefs 
in explaining variation in each dependent variable using a Wald test of the joint associations. 
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To evaluate Hypothesis 3, we added interaction terms to the multivariate model of sons' 
HPV vaccination willingness for the categorical measure of sons' age and each of the 
parents' HPV vaccine beliefs. Then, we conducted Wald tests of the joint associations of the 
interaction terms with sons' HPV vaccination willingness.
Paired and multivariate models controlled for parents' gender, age, and education, and sons' 
race, age, insurance status, and receipt of other vaccines. We did not include awareness in 
regression models because awareness could as easily be an outcome as a predictor of 
vaccination willingness. We evaluated multicollinearity in the multivariate models by 
estimating the tolerance values for each independent variable. Per guidelines for multiple 
regression analysis, we did not find that tolerance for any independent variable was below .
20,38 indicating that multicollinearity was not problematic for these models. We analyzed 
data with SAS version 9.4 (Cary, NC) using two-tailed statistical tests with a critical alpha 
of .05.
Results
Parents in the analytic sample were evenly split between female (53%) and male (47%) 
(Table 2). About half of parents had at least some college education (55%). Sons were 
evenly distributed across age categories. Most sons were non-Hispanic white (62%) and had 
health insurance (92%).
Awareness and beliefs
More parents than sons were aware of HPV (79% vs. 25%, respectively) and HPV vaccine 
(78% vs. 26%, respectively) (both p<.001) (Table 3). Among dyads in which both members 
were aware of HPV vaccine, parents and sons had equal, low levels of awareness that boys 
could receive the vaccine (44% vs. 38%, respectively).
More parents (43%) than sons (29%) indicated that they were willing to have the son receive 
HPV vaccine (p<.001). Compared to sons, parents reported greater importance of protecting 
the son and the community from HPV-related illness and higher likelihood of the son 
contracting HPV without vaccination (all p<.01), but they expected less pain from 
vaccination (p<.001). Responses on the other belief items were similar (all p>.05). 
Responses within the dyads were moderately correlated, ranging from r=.12 to .52 (all p<.
05) (Table 3).
Parents' HPV vaccination willingness
In paired models, parents' or sons' responses to each of the HPV vaccine beliefs were 
associated with parents' HPV vaccination willingness (Table 4). Results from the 
multivariate model of parents' willingness supported Hypothesis 1. Parents were more 
willing to vaccinate if they had higher anticipated regret of not vaccinating and the son later 
contracting HPV (odds ratio [OR]=1.72, 95% confidence interval [CI]=1.24, 2.40). 
However, the results did not support Hypothesis 2. Parents' willingness was not associated 
with their beliefs about the importance of vaccination for protecting the son.
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In addition, parents were more likely to be willing to have the son receive HPV vaccine if 
they reported higher levels of perceived importance of vaccination for protecting the son's 
future partner and if their sons had higher levels of perceived likelihood of contracting HPV 
(Table 4). Parents were less likely to be willing to vaccinate if they had higher anticipated 
regret of the son fainting after vaccination. Parents' own beliefs explained more variation in 
their willingness to vaccinate than sons' beliefs (Wald chi-square=14.67, p<.001).
Sons' HPV vaccination willingness
In paired models, parents' or sons' responses to each of the HPV vaccine beliefs were 
associated with sons' HPV vaccination willingness (Table 4). Results from the multivariate 
model of sons' willingness supported Hypothesis 1. Sons were more willing to vaccinate if 
they had higher anticipated regret of not getting HPV vaccine and later contracting HPV 
(OR=1.51, 95% CI=1.04, 2.19). The results partially supported Hypothesis 2. Sons were less 
willing to get the vaccine if they had greater concerns about vaccination side effects in terms 
of pain (OR=0.55, 95% CI=0.37, 0.82) but not fainting (OR=0.77, 95% CI=0.50, 1.04). The 
relationship between parents' beliefs and sons' vaccination willingness did not vary by sons' 
age (joint interaction p=.55), which did not provide support for Hypothesis 3.
Sons were also more likely to be willing to receive HPV vaccine if they reported higher 
levels of perceived importance of vaccination for protecting their future partner and 
perceived likelihood of contracting HPV (Table 4). They were less likely to be willing to 
vaccinate if their parents had higher levels of anticipated regret of fainting from vaccination. 
Sons' and parents' beliefs did not differ in how much they explained the variation in sons' 
willingness (Wald chi-square=0.62, p=.43).
Conclusion
Addressing low HPV vaccination coverage among adolescent males is a priority for the 
United States.39 In a national, probability-based study, less than half of parents and their 
adolescent sons were willing to vaccinate. Our findings suggest that HPV vaccination is the 
result of dyadic interactions between parents' and sons' beliefs. Increasing vaccination 
willingness through interventions targeting dyadic HPV vaccine beliefs could result in 
increased levels of uptake among adolescent boys.
In line with Hypothesis 1, both parents' and sons' vaccination willingness was associated 
with greater anticipated regret of the son contracting HPV if he did not get the vaccine. This 
finding builds on a large literature showing that anticipated regret is a powerful motivator of 
vaccination.21,22,40 A recent meta-analysis demonstrated that anticipated regret can be 
particularly effective in motivating health behaviors when highlighting the proximal and 
severe consequences of inaction.41 Although consequences of HPV infection (e.g., cancer) 
may not be proximal, they can be quite severe. In addition to anticipated regret, both parents' 
and sons' willingness was associated with greater perceived importance of protecting the 
son's future partner from HPV-related illness. Given that this construct was correlated with 
willingness for both dyad members, campaigns that address anticipated regret and the 
importance of protecting a son's future partner may be particularly promising for promoting 
vaccination among adolescent boys.
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Our results offered partial support for Hypothesis 2 – that concerns about long-term health 
effects of HPV infection and vaccination side effects would uniquely motivate willingness 
for parents and sons, respectively. Parents' HPV vaccination willingness was not associated 
with their beliefs about the importance of protecting sons from diseases caused by HPV 
infection in multivariate analysis. It is possible that parents did not fully understand the 
connection between HPV and diseases that could affect their sons (e.g., genital warts, anal 
cancer) because early vaccine promotion efforts emphasized the relationship between the 
vaccine and cervical cancer.42-44 Yet other constructs measuring closely related HPV 
vaccine beliefs (i.e., anticipated regret of HPV infection, importance of protecting the son's 
future partner, and perceived likelihood of HPV infection) were associated with willingness, 
providing some support for this hypothesis. However, as hypothesized, expectations about 
pain after vaccination were associated with sons' willingness, although we also found 
evidence for the negative association with parents' anticipated regret of fainting after 
vaccination. Parents and sons may overestimate the potential for vaccination side effects, 
which other studies have reported as minor and similar to side effects associated with other 
adolescent vaccines.45,46 Assuaging these fears could result in increased levels of HPV 
vaccination.
Although we hypothesized that parents' beliefs may be less important for vaccination 
willingness among older sons than among younger sons, we found that the relationship 
between parents' beliefs and sons' vaccination willingness did not vary by sons' age. These 
findings indicate that parent-son dyads implement similar HPV vaccination decision making 
processes when sons are between the ages of 11 and 17. It is possible that differences in the 
influence of parents' beliefs could emerge for behavioral outcomes (i.e., uptake of HPV 
vaccine) that did not arise when survey participants reported their vaccination willingness. 
Future studies are needed to expand on the influence of child's age on parent-child decision 
making.
Finally, we compared the contributions of each dyad member's beliefs to parents' and sons' 
vaccination willingness. Parents' beliefs explained more variation in parents' willingness 
than sons' beliefs, but there was no difference in how much parents' versus sons' beliefs 
explained variation in sons' willingness. This finding implies that parents make decisions 
about HPV vaccination with minimal influence from their sons' beliefs, while sons' 
willingness reflects both their own and their parents' beliefs. As such, interventions that 
focus on changing parents' beliefs may ultimately increase vaccination willingness for both 
parents and sons. However, it is important to recognize the independent relationship 
between sons' willingness and their own vaccine beliefs, especially for older adolescents 
who may be more involved in the decision-making process.
A few recent studies have demonstrated that adolescents themselves have a role to play in 
parents' vaccination intentions20,47,48 and their own vaccination behaviors.49,50 An 
underlying assumption of studies of adolescent vaccination that only include parents is 
either that adolescents do not influence uptake or that parents and adolescents hold such 
similar attitudes and beliefs that including both dyad members is redundant. As we have 
demonstrated in the present study, parents and adolescent sons have similar but not identical 
HPV vaccine beliefs, which in turn can influence their own and each other's vaccination 
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willingness. Although the paired models indicated that each of the HPV vaccine beliefs 
under study was associated with vaccination willingness, putting all of these paired beliefs 
into a multivariate model highlighted the unique influence of a small set of beliefs for both 
parents and sons: perceived importance of protecting a son's future sexual partner, perceived 
likelihood of HPV infection, anticipated regret of HPV infection if the son did not receive 
the vaccine, and anticipated regret of fainting after HPV vaccination.
Study strengths include use of dyadic analysis, which is a more valid evaluation of how 
parents and adolescents make HPV vaccination decisions together than studies involving 
only one of these groups. In addition, our results were robust to several sociodemographic 
and healthcare controls. In terms of limitations, data collection took place in 2010, a year 
before the CDC issued their recommendation for routine administration for boys, so the 
context in which families make HPV vaccination decisions may be different now than at the 
time of the study. Our study was cross-sectional, limiting our ability to draw causal 
inferences about behavior change; future studies should use longitudinal data or stage 
models of behavior change to understand how HPV vaccination willingness develops. 
Finally, we measured the dependent variable differently for parents versus sons (asking the 
latter how willing they were to vaccinate, but asking the former how willing they were to 
vaccinate if it were free). For parents, a no cost vaccine is the best-case scenario, and 
increasing willingness in that situation is a first step to encouraging parents who may have to 
pay for the vaccine.
In conclusion, we found that parents' and their adolescent sons' willingness to have the sons 
receive HPV vaccine was associated with their anticipated regret if the son were to contract 
HPV and the importance they placed on protecting the son's future partner from HPV-related 
illness. Future interventions can target these beliefs in order to encourage parents and sons to 
vaccinate, ultimately leading to increased HPV vaccine coverage and reduced rates of HPV-
related illness.
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• Parents and sons decide together whether to get human papillomavirus (HPV) 
vaccine.
• We analyzed dyadic effects of parents' and sons' beliefs on vaccine willingness.
• Anticipated regret of forgoing vaccination was higher in willing parents and 
sons.
• Concerns about vaccination side effects were lower in willing parents and sons.
• HPV vaccine promotion campaigns should target anticipated regret and side 
effects.
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Table 1
Questionnaire items in HPV Immunization in Sons (HIS) Study, 2010.
Construct Parent survey item Son survey item Response options
Awareness
Of HPV Have you heard of HPV or human 
papillomavirus before today?




Of HPV vaccine Have you ever heard of the HPV 
vaccine before today?




That males can receive HPV 
vaccine1
Before today, had you heard that the 
HPV vaccine can be given to guys?
Before today, had you heard that 





Perceived importance of son 
being protected
How important is it to you that [name] 
getting the HPV vaccine could protect 
him against genital warts and maybe 
some cancers?
How important is it to you that 
your getting the HPV vaccine 
could protect you against genital 
warts and maybe some cancers?
5 = Extremely important
4 = Very important
3 = Fairly important
2 = Slightly important
1 = Not at all important
Perceived importance of son's 
partner being protected
How important is it to you that [name] 
getting the HPV vaccine could protect 
his future girlfriend or wife against 
genital warts and maybe some cancers?
How important is it to you that 
your getting the HPV vaccine 
could protect your future girlfriend 
or wife against genital warts and 
maybe some cancers?
5 = Extremely important
4 = Very important
3 = Fairly important
2 = Slightly important
1 = Not at all important
Perceived importance of 
community being protected
How important is it to you that [name] 
getting the HPV vaccine could reduce 
genital warts and some cancers in the 
community?
How important is it to you that 
your getting the HPV vaccine 
could reduce genital warts and 
some cancers in the community?
5 = Extremely important
4 = Very important
3 = Fairly important
2 = Slightly important
1 = Not at all important
Perceived likelihood of HPV Without the vaccine, what do you think 
is the chance that [name] will ever get 
a disease caused by HPV?
Without the vaccine, what do you 
think is the chance that you will 
ever get a disease caused by HPV?
1 = No chance
2 = Low chance
3 = Moderate chance
4 = High chance
Anticipated regret of HPV 
infection
Imagine that [name] never got the HPV 
vaccine. He later got an HPV infection 
that could lead to health problems. 
How much would you regret that he 
did NOT get the HPV vaccine?
Imagine that you never got the 
HPV vaccine. You later got an 
HPV infection that could lead to 
health problems. How much would 
you regret that you did NOT get 
the HPV vaccine?
1 = Not at all
2 = A little
3 = A moderate amount
4 = A lot
Anticipated regret of fainting 
from vaccination
Imagine that [name] got the HPV 
vaccine and it made him faint (pass 
out). How much would you regret that 
he GOT the HPV vaccine?
Imagine that you got the HPV 
vaccine and it made you faint (pass 
out). How much would you regret 
that you GOT the HPV vaccine?
1 = Not at all
2 = A little
3 = A moderate amount
4 = A lot
Expected pain from HPV 
vaccination
If [name] got the HPV vaccine, how 
much pain would you expect him to 
have?
If you got the HPV vaccine, how 
much pain would you expect to 
have?
1= No pain
2 = Mild pain
3 = Moderate pain
4 = Severe pain
HPV vaccination willingness
Willingness How willing would you be to get the 
HPV vaccine for [name] if it was free?
How willing would you be to get 
the HPV vaccine?
5 = Definitely willing
4 = Probably willing
3 = Not sure
2 = Probably not willing
1 = Definitely not willing
1
Item only appeared for participants who were aware of HPV vaccine.
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Table 2




 Female 220 53.4
 Male 192 46.6
Age
 <45 years 248 60.2
 45 or older 164 39.8
Education level
 Less than college 186 45.2
 Some college or more 226 54.9
Son characteristics
Age
 11-12 years 125 30.3
 13-15 years 156 37.9
 16-17 years 131 31.8
Race/ethnicity
 Non-Hispanic white 254 61.7
 Non-Hispanic black 50 12.1
 Hispanic 64 15.5
 Other 44 10.7
Health insurance coverage
 Yes 377 91.5
 No 35 8.5
Received tetanus, diphtheria, and pertussis booster
 Yes 334 81.1
 No 78 18.9
Received meningococcal conjugate
 Yes 134 32.5
 No 278 67.5
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